Journal
TRANSPLANTATION
Volume 90, Issue 1, Pages 31-37Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/TP.0b013e3181de1d67
Keywords
Immunosuppression; Renal transplantation; Outcomes; Everolimus; Tacrolimus
Categories
Funding
- Novartis Pharmaceuticals Corporation